MARKET

CTSO

CTSO

Cytosorbents Corp
NASDAQ
0.8830
-0.0070
-0.79%
After Hours: 0.8800 -0.003 -0.34% 17:09 05/07 EDT
OPEN
0.9000
PREV CLOSE
0.8900
HIGH
0.9100
LOW
0.8705
VOLUME
58.63K
TURNOVER
--
52 WEEK HIGH
1.610
52 WEEK LOW
0.7000
MARKET CAP
55.28M
P/E (TTM)
-2.3200
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CTSO last week (0428-0502)?
Weekly Report · 2d ago
Cytosorbents: Hold Rating Amid Regulatory Challenges and Financial Uncertainty
TipRanks · 2d ago
Demystifying CytoSorbents: Insights From 4 Analyst Reviews
Benzinga · 5d ago
Cytosorbents Price Target Maintained With a $10.00/Share by D. Boral Capital
Dow Jones · 5d ago
Cytosorbents Is Maintained at Buy by D. Boral Capital
Dow Jones · 5d ago
D. Boral Capital Maintains Buy on CytoSorbents, Maintains $10 Price Target
Benzinga · 5d ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 5d ago
CytoSorbents: FDA issues denial letter for De Novo Request for DrugSorb-ATR
TipRanks · 6d ago
More
About CTSO
More
CytoSorbents Corporation is engaged in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery through blood purification. The Company’s blood purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Its lead product, CytoSorb, is an extracorporeal blood purification cartridge to reduce cytokine storms in common critical illnesses that can lead to massive inflammation, organ failure and patient death. Its products also include ECOS-300CY, VetResQ, DrugSorb-ATR, and PuriFi. DrugSorb-ATR is an investigational device that uses equivalent polymer technology to CytoSorb to address a large unmet need for blood thinner reversal in cardiothoracic surgery. ECOS-300CY is used to reduce cytokines and other inflammatory mediators when used in an ex vivo organ perfusion system.
Recently
Symbol
Price
%Change

Webull offers Cytosorbents Corp stock information, including NASDAQ: CTSO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CTSO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CTSO stock methods without spending real money on the virtual paper trading platform.